Bird Flu Surge in China Spurs H7N9 Pandemic Vaccine Preparations

A surge in bird flu cases in China increases the pandemic potential of the H7N9 strain, according to a Beijing-based supplier of influenza vaccines to the Chinese government.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.